Cadila slumps after Citi downgrade

Tags: Companies
Shares of Cadila Healthcare fall around 10 percent after Citigroup downgrades them to "sell" from "buy".

Citi says Cadila's valuations "have moved well ahead of fundamentals," despite gradual recovery in the sector and improving US business.

Prefers Aurobindo Pharma and Glenmark Pharmaceuticals in midcaps among drugmakers.

EDITORIAL OF THE DAY

  • Wean off the dependence on increased tax collection from diesel and petroleum

    As reported by this paper, despite international crude oil prices ruling in a range of $50 to $60, Indian consumers are paying the same prices as they

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Sandeep Bamzai

Cut & Thrust: Interesting times

Russia’s ultra nationalist supreme leader, the all powerful Vladimir Putin ...

Sachin Shridhar

Strip numbers, see truth

Indian Parliament has over has over 34 per cent of ...

Rajgopal Nidamboor

That divine mosaic of art and science

Our old, inborn fancy to present complex explanations as a ...